Daejeon, South Korea

Jiyun Mun

This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiyun Mun. Retrieved from https://idiyas.com/inventor/jiyun-mun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jiyun Mun and Research on an Anti-Inflammatory Composition.

Introduction

Jiyun Mun is an inventor based in Daejeon, South Korea, whose work includes research into potential treatments for inflammatory diseases. She is associated with the Korea Research Institute of Bioscience and Biotechnology and is credited with 1 patent.

Latest Patents

Mun’s patent, “Anti-inflammatory composition comprising acylhydrazone derivative,” describes a composition intended to prevent, alleviate, or treat inflammatory diseases. It uses an acylhydrazone derivative, a stereoisomer of the compound, or a pharmaceutically acceptable salt as its active ingredient.

According to the patent description, the composition inhibits inflammatory cytokines and inflammatory signaling pathways. The research identifies dermatitis as one example of an inflammatory condition whose symptoms the composition may help alleviate.

Career Highlights

Mun’s listed patent reflects research at the intersection of biotechnology and therapeutic development. Her work is associated with the Korea Research Institute of Bioscience and Biotechnology in Daejeon.

Collaborations

The patent’s listed collaborators include Sung-Kyun Ko and Srinivasrao Ganipisetti.

Conclusion

Jiyun Mun’s patent focuses on an acylhydrazone-based composition with potential applications in preventing, alleviating, or treating inflammatory diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…